Answers are grounded in this paper and cite their sources.
Stopping Therapy for Alpha1-Antitrypsin Deficiency In Ireland, augmentation treatment of patients with genetic alpha1-antitrypsin deficiency was abruptly discontinued when government–industry price...
No takes yet. Share an insight, caveat, or question.
McElvaney et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: